Skip to main content

Post-IPO Equity Pharmaceutical Companies

Explore 204 pharmaceutical startups that raised post-ipo equity funding. Access verified founder contact information and fundraising data.

Total Companies
204
Total Funding
$2.0B
Avg Funding
$78.5M
Cities
25

Export 204 Post-IPO Equity Pharmaceutical Companies

Get founder emails, funding data, and company details in one CSV

Start Free Trial

Recently Funded Companies

Export
Laguna Hills, United States
$19.0M
raised

Adagio Medical is engaged in the research and development of treatments for cardiovascular diseases.

Oct 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

New York, United States
$11.0M
raised

TAO Synergies is a clinical-stage biopharmaceutical company that develops novel therapies for neurodegenerative diseases.

Oct 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

London, United Kingdom
$2.0M
raised

Aptorum Group is a pharmaceutical company dedicated to the development of therapeutic assets to treat diseases with unmet medical needs.

Oct 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ashburn, United States
$104.5M
raised

Quoin Pharmaceuticals is into developing products which address major unmet medical needs.

Oct 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Framingham, United States
$4.5M
raised

Xenetic Biosciences is a biopharmaceutical company that provides drugs, cancer therapies, and vaccines.

Oct 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 204 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Los Altos, United States
$100.0M
raised

Semnur Pharmaceuticals is a specialty pharmaceutical company focusing on clinical and commercial development of innovative products.

Sep 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Toronto, Canada
$754K
raised

Satellos Bioscience is a private regenerative medicine company developing novel therapeutics that stimulate or restore muscle regeneration.

Sep 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

San Diego, United States
$690.0M
raised

Synapse Energy Economics is a consulting firm providing economic and policy analysis for the electric power sector.

Sep 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Cambridge, United States
$175.0M
raised

Amylyx Pharmaceuticals specializes in providing solutions for Alzheimer’s and other diseases of the brain.

Sep 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Florida, United States
$5.3M
raised

Nutriband is an innovative and progressive health and lifestyle company.

Sep 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 204 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Baltimore, United States
$7.0M
raised

TNF Pharmaceuticals is researching groundbreaking treatments to address serious and debilitating autoimmune and inflammatory illnesses.

Sep 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Westbrook, United States
$4.4M
raised

One of the most innovative consumer healthcare and beauty companies in North America.

Aug 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Melville, United States
$400.0M
raised

Sharps Technology makes single-use syringes that help prevent accidental needle sticks and make injections safer

Aug 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

New Haven, United States

Arvinas advances therapies degrading disease-causing proteins for life-threatening diseases, from discovery to commercialization.

Aug 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Pointe-claire, Canada
$1.7M
raised

Devonian is a late stage botanical pharmaceutical corporation

Aug 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 204 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Wexford, United States
$4.0M
raised

Coeptis Therapeutics is a biopharmaceutical company that focuses on the development and acquisition of cell therapy platforms for patients.

Aug 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Dublin, Ireland
$2.2M
raised

Iterum Therapeutics is a clinical-stage pharmaceutical company that develops significantly differentiated anti-infectives.

Aug 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Vaughan, Canada
$66K
raised

Revive Therapeutics is focused on the research, development and commercialization ofnovel therapies and technologies company.

Jul 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Sydney, Australia
$132.4M
raised

Clarity Pharmaceuticals is a personalized medicine company focused on the treatment of serious disease.

Jul 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

South San Francisco, United States
$100.0M
raised

Lyell Immunopharma is an operator of a biotechnology company that develops cellular therapies to cure cancer.

Jul 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 204 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Bethesda, United States
$7.0M
raised

Gain Therapeutics is a biotech company developing pharmacological chaperones drugs designed to treat rare metabolic disorders.

Jul 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Washington, United States
$5.0M
raised

60 Degrees Pharmaceuticals develops and commercializes new medicines to treat and prevent infectious diseases.

Jul 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Boston, United States
$175.0M
raised

Rhythm is a biopharmaceutical company focused on developing and commercializing peptide therapeutics

Jul 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Woburn, United States
$8.5M
raised

Biofrontera is a biopharmaceutical company specializing in photodynamic therapy and topical antibiotics.

Jun 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Stockholm, Sweden
$3.0M
raised

Modus Therapeutics is a Swedish drug development company focused on normalizing the lives for patients with Sickle Cell Disease.

Jun 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Showing 101 to 125 of 204 companies

Ready to Connect with Post-IPO Equity Pharmaceutical Startups?

Get verified founder emails, funding details, and company data for 204 post-ipo equity pharmaceutical companies.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked

204 Pharmaceutical Post-IPO Equity Startups (November 2026) — Page 5 | VCBacked